+A A-

M.D. Medical Oncologist Mustafa Canhoroz

Name
Medical Oncologist Mustafa Canhoroz
Title
M.D.
Phone
+90 850 460 63 34
E-Mail
medicanaipc@medicana.com.tr

Hospital Medicana Bursa Hospital


Department Medical Oncology


Academic Title Medical Oncologist                         


Physician Name Mustafa Canhoroz, Medical Oncologist


Graduate Education Istanbul University, Cerrahpasa School of Medicine (2001)


Postgraduate Education (Residency) Haydarpaşa Numune Education and Research Hospital, Department of Internal Medicine (2005)

 

Uludağ University School of Medicine, Department of  Medical Oncology Residency Program (2011)

 
Area of Expertise Medicial Oncology

 

Solid Organ Cancer Treatment

 

Palliative Care

 

Experience Adıyaman 82. Yıl State Hospital (2007-2008)

 

Fırat University School of Medicine, Department of   Medical Oncology (2012-2013)

 

Acıbadem Eskisehir Hospital (2013-2017)

 

Private Ceylan Hospital (2017-2019)

 

Medicana Bursa Hospital, Department of Medical Oncology (2019-present)

 

Scientific Publications

Prognostic significance of estrogen receptor, progesterone receptor, HER2/neu, Ki-67, and nm23 expression in patients with invasive breast cancer

E Cubukcu, O Kanat, O Fatih Olmez, S Kabul, M Canhoroz, N Avci, ...

J BUON 18 (2), 359-365 16  2013

Comparison of three different treatment modalities in the management of cancer cachexia

O Kanat, E Cubukcu, N Avci, F Budak, I Ercan, M Canhoroz, F Olmez

Tumori Journal 99 (2), 229-233 16 2013

XRCC1 Gene Polymorphisms and Risk of Lung Cancer in Turkish Patients

M Karkucak, T Yakut, T Evrensel, A Deligonul, T Gulten, G Ocakoglu, ...

International Journal of Human Genetics 12 (2), 113-117 16  2012

Comparison of second-line treatment outcomes 

between sensitive and refractory small cell lung cancer patients: a retrospective analysis

T Korkmaz, S Seber, U Kefeli, E Sari, M Canhoroz, B Oven, E Yildirim, ...

Clinical and Translational Oncology 15 (7), 535-540  15 2013

Primary small cell carcinoma of the breast: report of seven cases and review of the literature.

O Kanat, S Kilickap, T Korkmaz, BBU Oven, M Canhoroz, E Cubukcu, ...

Tumori 97 (4), 473 10 2011

Clinical significance of adiponectin expression in colon cancer patients

M Canhoroz, O Kanat, O Saraydaroglu, E Buluc, N Avci, E Cubukcu, ...

Journal of cancer research and therapeutics 10 (2), 347 8  2014

Lack of prognostic significance of adiponectin immunohistochemical expression in patients with triple-negative breast cancer

E Cubukcu, OF Olmez, O Kanat, S Kabul, M Canhoroz, N Avci, M Hartavi, ...

Contemporary Oncology 18 (1), 34  4 2014

A rare occurrence of primary T-cell lymphoma of the breast in pregnancy.

K Ozkan, G Sehsuvar, C Erdem, C Mustafa, S Ibrahim, O Fatih

Acta oncologica (Stockholm, Sweden)  4 2011

The prevalance of herbal product use as a alternative medicine among cancer patients in Turkey

N Avci, M Canhoroz, O Kanat, MS Guru

JOURNAL OF CLINICAL AND ANALYTICAL MEDICINE 6 (3), 327-330 3 2015

Prognostic significance of human epidermal receptor (HER)-3 immunohistochemical expression in patients with metastatic breast cancer

OF Olmez, T Evrensel, E Cubukcu, N Ugras, N Avci, M Canhoroz, ...

Asian Pacific Journal of Cancer Prevention 14 (7), 4115-4119 3 2013

Identification of prognostic factors in patients with metastatic gastrointestinal stromal tumors.

E Cubukcu, OF Olmez, N Avci, M Canhoroz, E Kurt, O Kanat, T Evrensel, ...

Journal of BU ON.: official journal of the Balkan Union of Oncology 17 3 … 2 2012

A case of conjunctival melanoma presenting with breast metastasis

M Canhoroz, I Yogurt, S Gokgoz, U Topal, O Kanat